| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | alkaline phosphatase activity | 1.23e-04 | 6 | 58 | 2 | GO:0004035 | |
| GeneOntologyBiologicalProcess | establishment of skin barrier | 4.58e-06 | 41 | 56 | 4 | GO:0061436 | |
| GeneOntologyCellularComponent | keratohyalin granule | 2.24e-07 | 5 | 60 | 3 | GO:0036457 | |
| GeneOntologyCellularComponent | cornified envelope | 1.60e-06 | 69 | 60 | 5 | GO:0001533 | |
| HumanPheno | Short attention span | 1.02e-04 | 517 | 21 | 9 | HP:0000736 | |
| HumanPheno | Reduced attention regulation | 1.17e-04 | 526 | 21 | 9 | HP:5200044 | |
| HumanPheno | Abnormal size of the palpebral fissures | 1.25e-04 | 298 | 21 | 7 | HP:0200007 | |
| HumanPheno | Attention deficit hyperactivity disorder | 1.38e-04 | 413 | 21 | 8 | HP:0007018 | |
| HumanPheno | Autistic behavior | 1.44e-04 | 678 | 21 | 10 | HP:0000729 | |
| HumanPheno | Abnormality of salivation | 1.68e-04 | 215 | 21 | 6 | HP:0100755 | |
| Domain | S100_CABP | 1.60e-06 | 27 | 60 | 4 | PS00303 | |
| Domain | S_100 | 1.60e-06 | 27 | 60 | 4 | PF01023 | |
| Domain | S100_Ca-bd_sub | 1.86e-06 | 28 | 60 | 4 | IPR013787 | |
| Domain | S100/CaBP-9k_CS | 1.86e-06 | 28 | 60 | 4 | IPR001751 | |
| Domain | S_100 | 1.86e-06 | 28 | 60 | 4 | SM01394 | |
| Domain | Filaggrin | 1.01e-05 | 2 | 60 | 2 | IPR003303 | |
| Domain | SPAR_C | 3.04e-05 | 3 | 60 | 2 | PF11881 | |
| Domain | SIPA1L_C | 3.04e-05 | 3 | 60 | 2 | IPR021818 | |
| Domain | Alk_phosphatase | 6.06e-05 | 4 | 60 | 2 | PF00245 | |
| Domain | Alkaline_phosphatase_AS | 6.06e-05 | 4 | 60 | 2 | IPR018299 | |
| Domain | Alkaline_phosphatase | 6.06e-05 | 4 | 60 | 2 | IPR001952 | |
| Domain | alkPPc | 6.06e-05 | 4 | 60 | 2 | SM00098 | |
| Domain | ALKALINE_PHOSPHATASE | 6.06e-05 | 4 | 60 | 2 | PS00123 | |
| Domain | Rap_GAP | 4.49e-04 | 10 | 60 | 2 | PF02145 | |
| Domain | Rap_GAP_dom | 5.48e-04 | 11 | 60 | 2 | IPR000331 | |
| Domain | RAPGAP | 5.48e-04 | 11 | 60 | 2 | PS50085 | |
| Domain | EF_Hand_1_Ca_BS | 2.41e-03 | 175 | 60 | 4 | IPR018247 | |
| Domain | EF_HAND_1 | 4.18e-03 | 204 | 60 | 4 | PS00018 | |
| Domain | Alkaline_phosphatase_core | 4.44e-03 | 31 | 60 | 2 | IPR017850 | |
| Domain | Alkaline_Pase-like_a/b/a | 4.44e-03 | 31 | 60 | 2 | IPR017849 | |
| Domain | - | 4.44e-03 | 31 | 60 | 2 | 3.40.720.10 | |
| Domain | EF_HAND_2 | 6.47e-03 | 231 | 60 | 4 | PS50222 | |
| Domain | EF_hand_dom | 6.57e-03 | 232 | 60 | 4 | IPR002048 | |
| Pubmed | Defects of filaggrin-like proteins in both lesional and nonlesional atopic skin. | 5.66e-09 | 3 | 63 | 3 | 23403047 | |
| Pubmed | 2.24e-06 | 209 | 63 | 6 | 36779422 | ||
| Pubmed | Human placental and intestinal alkaline phosphatase genes map to 2q34-q37. | 3.23e-06 | 2 | 63 | 2 | 3687940 | |
| Pubmed | Atopic Dermatitis Susceptibility Variants in Filaggrin Hitchhike Hornerin Selective Sweep. | 3.23e-06 | 2 | 63 | 2 | 27678121 | |
| Pubmed | Placental and intestinal alkaline phosphatases are receptors for Aeromonas sobria hemolysin. | 3.23e-06 | 2 | 63 | 2 | 15715171 | |
| Pubmed | An ATIPical family of angiotensin II AT2 receptor-interacting proteins. | 3.23e-06 | 2 | 63 | 2 | 20889352 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 26364583 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 24813994 | ||
| Pubmed | 5.38e-06 | 19 | 63 | 3 | 31345929 | ||
| Pubmed | Variation in genes of the epidermal differentiation complex in German atopic dermatitis patients. | 7.36e-06 | 21 | 63 | 3 | 19601998 | |
| Pubmed | 8.99e-06 | 407 | 63 | 7 | 12693553 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 1321014 | ||
| Pubmed | Two gene duplication events in the evolution of the human heat-stable alkaline phosphatases. | 9.68e-06 | 3 | 63 | 2 | 3443302 | |
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 19008955 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 19407215 | ||
| Pubmed | Genomic structure and comparison of mouse tissue-specific alkaline phosphatase genes. | 9.68e-06 | 3 | 63 | 2 | 2286375 | |
| Pubmed | GATA3 regulates FLG and FLG2 expression in human primary keratinocytes. | 9.68e-06 | 3 | 63 | 2 | 28928464 | |
| Pubmed | Intestinal Alkaline Phosphatase Regulates Tight Junction Protein Levels. | 9.68e-06 | 3 | 63 | 2 | 27106638 | |
| Pubmed | Organic pyrophosphates as substrates for human alkaline phosphatases. | 9.68e-06 | 3 | 63 | 2 | 16742561 | |
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 10767088 | ||
| Pubmed | MUSEAP, a novel reporter gene for the study of long-term gene expression in immunocompetent mice. | 9.68e-06 | 3 | 63 | 2 | 11722850 | |
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 32437351 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 18774391 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 23495698 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 17901166 | ||
| Pubmed | RapGAPs in brain: multipurpose players in neuronal Rap signalling. | 9.68e-06 | 3 | 63 | 2 | 20576033 | |
| Pubmed | Analysis of SPINK 5, KLK 7 and FLG genotypes in a French atopic dermatitis cohort. | 9.68e-06 | 3 | 63 | 2 | 17989887 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 1.03e-05 | 774 | 63 | 9 | 15302935 | |
| Pubmed | CELSR1 INTS5 SETD5 IGHMBP2 SIPA1L1 SIPA1L3 TNRC6A DNMBP SPEN INO80D MFF FAM83B | 1.35e-05 | 1497 | 63 | 12 | 31527615 | |
| Pubmed | 1.61e-05 | 83 | 63 | 4 | 23568457 | ||
| Pubmed | 1.93e-05 | 4 | 63 | 2 | 21900644 | ||
| Pubmed | 1.93e-05 | 4 | 63 | 2 | 39273477 | ||
| Pubmed | Structural evidence of functional divergence in human alkaline phosphatases. | 1.93e-05 | 4 | 63 | 2 | 12372831 | |
| Pubmed | 1.93e-05 | 4 | 63 | 2 | 9061447 | ||
| Pubmed | 1.93e-05 | 4 | 63 | 2 | 9056646 | ||
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 2.15e-05 | 184 | 63 | 5 | 32908313 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 2.40e-05 | 861 | 63 | 9 | 36931259 | |
| Pubmed | Central role of pyrophosphate in acellular cementum formation. | 3.22e-05 | 5 | 63 | 2 | 22675556 | |
| Pubmed | The mouse homolog of the orphan nuclear receptor tailless is expressed in the developing forebrain. | 3.22e-05 | 5 | 63 | 2 | 7720587 | |
| Pubmed | Two alkaline phosphatase genes are expressed during early development in the mouse embryo. | 3.22e-05 | 5 | 63 | 2 | 2133555 | |
| Pubmed | 3.22e-05 | 5 | 63 | 2 | 9291464 | ||
| Pubmed | 3.61e-05 | 205 | 63 | 5 | 20436479 | ||
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 3.87e-05 | 208 | 63 | 5 | 33230847 | |
| Pubmed | 4.73e-05 | 217 | 63 | 5 | 34048709 | ||
| Pubmed | 4.82e-05 | 6 | 63 | 2 | 27304082 | ||
| Pubmed | 4.82e-05 | 6 | 63 | 2 | 14526104 | ||
| Pubmed | Hydrolysis and absorption of pantothenate and its coenzymes in the rat small intestine. | 4.82e-05 | 6 | 63 | 2 | 6619987 | |
| Pubmed | 4.82e-05 | 6 | 63 | 2 | 10878613 | ||
| Pubmed | Emx1 and Emx2 functions in development of dorsal telencephalon. | 6.74e-05 | 7 | 63 | 2 | 9006071 | |
| Pubmed | 6.74e-05 | 7 | 63 | 2 | 17164413 | ||
| Pubmed | 6.74e-05 | 7 | 63 | 2 | 26831517 | ||
| Pubmed | Winged helix transcription factor BF-1 is essential for the development of the cerebral hemispheres. | 6.74e-05 | 7 | 63 | 2 | 7605629 | |
| Pubmed | Frizzled6 deficiency disrupts the differentiation process of nail development. | 6.74e-05 | 7 | 63 | 2 | 23439395 | |
| Pubmed | 7.32e-05 | 122 | 63 | 4 | 30773093 | ||
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | 9.97e-05 | 410 | 63 | 6 | 26949251 | |
| Pubmed | 1.15e-04 | 9 | 63 | 2 | 18326838 | ||
| Pubmed | microRNA-184 Induces a Commitment Switch to Epidermal Differentiation. | 1.15e-04 | 9 | 63 | 2 | 29198823 | |
| Pubmed | A Runx2/miR-3960/miR-2861 regulatory feedback loop during mouse osteoblast differentiation. | 1.15e-04 | 9 | 63 | 2 | 21324897 | |
| Pubmed | 1.17e-04 | 52 | 63 | 3 | 9455477 | ||
| Pubmed | Complex arrangement of genes within a 220-kb region of double-duplicated DNA on human 2q37.1. | 1.44e-04 | 10 | 63 | 2 | 11352565 | |
| Pubmed | Multimodal spatiotemporal transcriptomic resolution of embryonic palate osteogenesis. | 1.44e-04 | 10 | 63 | 2 | 37709732 | |
| Pubmed | 1.44e-04 | 10 | 63 | 2 | 26989131 | ||
| Pubmed | Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche. | 1.58e-04 | 149 | 63 | 4 | 25231870 | |
| Pubmed | 1.74e-04 | 1116 | 63 | 9 | 31753913 | ||
| Pubmed | IFN-λ derived from nonsusceptible enterocytes acts on tuft cells to limit persistent norovirus. | 1.76e-04 | 11 | 63 | 2 | 37703370 | |
| Pubmed | A dual role for planar cell polarity genes in ciliated cells. | 1.76e-04 | 11 | 63 | 2 | 25024228 | |
| Pubmed | 1.98e-04 | 62 | 63 | 3 | 26644517 | ||
| Pubmed | A YY1-dependent increase in aerobic metabolism is indispensable for intestinal organogenesis. | 2.11e-04 | 12 | 63 | 2 | 27802136 | |
| Pubmed | 2.11e-04 | 12 | 63 | 2 | 31289197 | ||
| Pubmed | Patterning of the dorsal telencephalon and cerebral cortex by a roof plate-Lhx2 pathway. | 2.11e-04 | 12 | 63 | 2 | 11719201 | |
| Pubmed | LncRNA SAMD12-AS1 promotes cell proliferation and inhibits apoptosis by interacting with NPM1. | 2.11e-04 | 12 | 63 | 2 | 31406141 | |
| Pubmed | The Rb/E2F pathway modulates neurogenesis through direct regulation of the Dlx1/Dlx2 bigene cluster. | 2.49e-04 | 13 | 63 | 2 | 22699903 | |
| Pubmed | Establishment of smooth muscle and cartilage juxtaposition in the developing mouse upper airways. | 2.49e-04 | 13 | 63 | 2 | 24218621 | |
| Pubmed | 2.49e-04 | 13 | 63 | 2 | 21552538 | ||
| Pubmed | 2.90e-04 | 14 | 63 | 2 | 36639541 | ||
| Pubmed | 2.90e-04 | 14 | 63 | 2 | 27551807 | ||
| Pubmed | PRDM14 directly interacts with heat shock proteins HSP90α and glucose-regulated protein 78. | 2.90e-04 | 14 | 63 | 2 | 29178343 | |
| Pubmed | 3.04e-04 | 504 | 63 | 6 | 34432599 | ||
| Pubmed | Expression of the winged helix genes fkh-4 and fkh-5 defines domains in the central nervous system. | 3.81e-04 | 16 | 63 | 2 | 8861101 | |
| Pubmed | 3.81e-04 | 16 | 63 | 2 | 31823782 | ||
| Pubmed | 3.81e-04 | 16 | 63 | 2 | 31092921 | ||
| Pubmed | 3.93e-04 | 529 | 63 | 6 | 14621295 | ||
| Pubmed | 4.32e-04 | 17 | 63 | 2 | 37479688 | ||
| Pubmed | 4.90e-04 | 1285 | 63 | 9 | 35914814 | ||
| Pubmed | 5.05e-04 | 777 | 63 | 7 | 35844135 | ||
| Pubmed | 5.41e-04 | 19 | 63 | 2 | 25249461 | ||
| Pubmed | Dnmt1 is essential to maintain progenitors in the perinatal intestinal epithelium. | 6.01e-04 | 20 | 63 | 2 | 26023099 | |
| Pubmed | 6.01e-04 | 20 | 63 | 2 | 12743021 | ||
| Pubmed | Zinc-finger genes Fez and Fez-like function in the establishment of diencephalon subdivisions. | 6.01e-04 | 20 | 63 | 2 | 16971467 | |
| Pubmed | Distinct regulatory cascades govern extraocular and pharyngeal arch muscle progenitor cell fates. | 6.01e-04 | 20 | 63 | 2 | 19531352 | |
| Pubmed | TRIM25 and DEAD-Box RNA Helicase DDX3X Cooperate to Regulate RIG-I-Mediated Antiviral Immunity. | 6.14e-04 | 91 | 63 | 3 | 34445801 | |
| Pubmed | The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis. | 6.70e-04 | 218 | 63 | 4 | 33378226 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 6.84e-04 | 588 | 63 | 6 | 38580884 | |
| Pubmed | Functional roles of Lgr4 and Lgr5 in embryonic gut, kidney and skin development in mice. | 7.97e-04 | 23 | 63 | 2 | 24680895 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 8.34e-04 | 1105 | 63 | 8 | 35748872 | |
| Pubmed | Emx2 directs the development of diencephalon in cooperation with Otx2. | 8.69e-04 | 24 | 63 | 2 | 11493561 | |
| Pubmed | 8.69e-04 | 24 | 63 | 2 | 21982646 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | 8.74e-04 | 853 | 63 | 7 | 28718761 | |
| Pubmed | 9.43e-04 | 25 | 63 | 2 | 36067211 | ||
| Pubmed | 9.87e-04 | 242 | 63 | 4 | 34011540 | ||
| Cytoband | 1q21.3 | 2.12e-05 | 117 | 63 | 4 | 1q21.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16p12 | 9.54e-05 | 172 | 63 | 4 | chr16p12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q21 | 2.38e-04 | 404 | 63 | 5 | chr1q21 | |
| Cytoband | 16p12.3 | 1.01e-03 | 34 | 63 | 2 | 16p12.3 | |
| GeneFamily | EF-hand domain containing|S100 fused type protein family | 8.76e-10 | 7 | 42 | 4 | 1350 | |
| GeneFamily | Alkaline phosphatases | 3.15e-05 | 4 | 42 | 2 | 1072 | |
| GeneFamily | EF-hand domain containing | 1.63e-03 | 219 | 42 | 4 | 863 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 3.08e-06 | 159 | 63 | 5 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma-Skin_Cutaneous_Melanoma-6|TCGA-Skin / Sample_Type by Project: Shred V9 | 6.80e-06 | 187 | 63 | 5 | 2ca7928baf0c5e61f7294ed05e6e6f0e0adf9d3f | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 6.97e-06 | 188 | 63 | 5 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | COVID-19-lung-Secretory|lung / Disease (COVID-19 only), tissue and cell type | 7.16e-06 | 189 | 63 | 5 | 84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 9.19e-06 | 199 | 63 | 5 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13-Mesenchymal-Mesoderm|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 9.41e-06 | 200 | 63 | 5 | 0f4b8b0868bda406fe6bf01d1b722510fdfd0168 | |
| ToppCell | Control-Epithelial_airway|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.42e-05 | 158 | 63 | 4 | 35aee1c3b92169e73569331022833cb44ab7e7e8 | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.42e-05 | 158 | 63 | 4 | d78e7e52657dc094430291fec07e9c298be9e584 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Tubular-6|TCGA-Stomach / Sample_Type by Project: Shred V9 | 7.61e-05 | 159 | 63 | 4 | 655c0749c238bd68cb797adb83e25a23b8a3cc9d | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.20e-05 | 167 | 63 | 4 | c87ebfa8c3284ad33579190e148c95bcaf670d17 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.20e-05 | 167 | 63 | 4 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_B|GI_small-bowel / Manually curated celltypes from each tissue | 9.41e-05 | 168 | 63 | 4 | 5535c1b8b7fde7b59a1bc0580cebdfa963aa1c39 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_B-Memory_B_cells|GI_small-bowel / Manually curated celltypes from each tissue | 9.41e-05 | 168 | 63 | 4 | 8e025bb0541746e232b77ac0e31412ae71420c47 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Hematologic-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.63e-05 | 169 | 63 | 4 | 4e1322cc5e1733e9fb19e08f739a30206f43cea8 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.85e-05 | 170 | 63 | 4 | 2d880223d01bde4bf777bd6f50b7d2768489075f | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.85e-05 | 170 | 63 | 4 | 0cc20322cb3e3e7bbd4daad8785c99f80e355c16 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.01e-04 | 171 | 63 | 4 | b51bbeacb172e8b5de519ada85543d7ae9914b3c | |
| ToppCell | droplet-Fat-Bat-18m-Mesenchymal-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 175 | 63 | 4 | b4f01e7782cdd107d0817ef601891fd3a382bc35 | |
| ToppCell | droplet-Fat-Bat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 175 | 63 | 4 | ef6f811d8e1839f405c3b41090ddf79be57a099f | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW10-Neuronal-GABAergic_neurons|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 1.10e-04 | 175 | 63 | 4 | d4ff1f197ad4086286e86817cbff24fa718293fc | |
| ToppCell | droplet-Fat-Bat-18m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 175 | 63 | 4 | 7f7598d46d10bff1cbea42f950bdde1aaa16e9a4 | |
| ToppCell | LPS-IL1RA+antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.15e-04 | 177 | 63 | 4 | b7fee75de7e96924af488a5baa2334711889ae7c | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_1|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.15e-04 | 177 | 63 | 4 | 36b5d29caa9cffbc0284f771a4db71aa72171a89 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 1.36e-04 | 185 | 63 | 4 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Treg_cell_1|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.39e-04 | 186 | 63 | 4 | 76cbc3610aedf8c19c17ad5faf6ef5e8980b6af5 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.42e-04 | 187 | 63 | 4 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-H_(AT1)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.45e-04 | 188 | 63 | 4 | 61422c7919ca0ea02d6be4302f11b169a3ce35e5 | |
| ToppCell | 10x5'-GI_large-bowel-Myeloid_Monocytic|GI_large-bowel / Manually curated celltypes from each tissue | 1.45e-04 | 188 | 63 | 4 | d0045fdda757d191dabc7853f6a6e99c0e97d93d | |
| ToppCell | 367C-Epithelial_cells-Epithelial-H_(AT1)|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.45e-04 | 188 | 63 | 4 | 18698f0b22ccbc2b93759acc1c8dbdb30a6b5a16 | |
| ToppCell | 10x5'-GI_large-bowel-Myeloid_Monocytic-Classical_monocytes|GI_large-bowel / Manually curated celltypes from each tissue | 1.45e-04 | 188 | 63 | 4 | 0bcf04aa47738f43c1a87dae5dc487738ee86f8c | |
| ToppCell | TCGA-Skin-Primary_Tumor|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.51e-04 | 190 | 63 | 4 | e2b26a03c6ab24d9b0f4150c47597be37767d86e | |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.51e-04 | 190 | 63 | 4 | 01fb45add4661bc86cd0a34fac35177907152dbb | |
| ToppCell | COVID-19-Epithelial_cells-Airway_goblet|COVID-19 / group, cell type (main and fine annotations) | 1.51e-04 | 190 | 63 | 4 | 51ca9ef4df3220487152fcf684147730637c7cc1 | |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma-Skin_Cutaneous_Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.51e-04 | 190 | 63 | 4 | 3188c7bd225cbcf46a21e2fb784336cdd9665995 | |
| ToppCell | COPD-Myeloid-cDC2|World / Disease state, Lineage and Cell class | 1.54e-04 | 191 | 63 | 4 | 4e4887175200a57e1b041f2f131e3df774df3509 | |
| ToppCell | COPD-Myeloid-cDC2|COPD / Disease state, Lineage and Cell class | 1.54e-04 | 191 | 63 | 4 | 2af6e4a6bd1f2193ece2131c3b7d976dd23a6966 | |
| ToppCell | COPD-Myeloid-cDC2|Myeloid / Disease state, Lineage and Cell class | 1.57e-04 | 192 | 63 | 4 | 984cdc2f1d93e164bc946d63f58dacb629f82eb7 | |
| ToppCell | LV-08._Macrophage|LV / Chamber and Cluster_Paper | 1.57e-04 | 192 | 63 | 4 | 7be12d580aaf2f2f1562203fcad3a44639b8c5a6 | |
| ToppCell | Epithelial-club_cell|World / Lineage, Cell type, age group and donor | 1.60e-04 | 193 | 63 | 4 | 2bdd09004fa433550958ec42ba4b06271a4aaf7c | |
| ToppCell | COPD-Myeloid-Macrophage|World / Disease state, Lineage and Cell class | 1.64e-04 | 194 | 63 | 4 | 7d682408e9a6239a4e47befc9376e760cc3d133a | |
| ToppCell | severe-B_cell|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.67e-04 | 195 | 63 | 4 | 0fc3c605609c9e6bdea15d73c45def2188ae5fb1 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 1.70e-04 | 196 | 63 | 4 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.70e-04 | 196 | 63 | 4 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | NS-critical-LOC-Epithelial-Squamous|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.70e-04 | 196 | 63 | 4 | 453c809494ceffa2a28af283c4b5a4924fcf160f | |
| ToppCell | LPS_IL1RA_TNF|World / Treatment groups by lineage, cell group, cell type | 1.74e-04 | 197 | 63 | 4 | 0a6550dce156fc81f15b1e7830d331ca50d87d06 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.77e-04 | 198 | 63 | 4 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.77e-04 | 198 | 63 | 4 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.77e-04 | 198 | 63 | 4 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.77e-04 | 198 | 63 | 4 | 6ba5e5970109a04ed968bac7ff099ae250c579dc | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.77e-04 | 198 | 63 | 4 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35|World / Primary Cells by Cluster | 1.77e-04 | 198 | 63 | 4 | de5214a85fe017eb23d4aa8af624464f062ec57e | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.77e-04 | 198 | 63 | 4 | 5fc25b008a4d8d6bec83923a16f64dd9e1ff1f2d | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.77e-04 | 198 | 63 | 4 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.80e-04 | 199 | 63 | 4 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M|organoid_Kanton_Nature / Sample Type, Dataset, Time_group, and Cell type. | 1.80e-04 | 199 | 63 | 4 | b2d7dea11207cca63d688f8051143850b29dbdf0 | |
| ToppCell | Transverse-Macrophage-LYVE1_Macrophage|Transverse / Region, Cell class and subclass | 1.80e-04 | 199 | 63 | 4 | facf79c256db5ae57bdb613e86ec90616a6f67ca | |
| ToppCell | Transverse-(6)_Macrophage-(61)_LYVE1_Macrophage|Transverse / shred on region, Cell_type, and subtype | 1.80e-04 | 199 | 63 | 4 | dcc2a7f4d1fa30aaaad655dd59c5a2b039d264bf | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 1.84e-04 | 200 | 63 | 4 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 1.84e-04 | 200 | 63 | 4 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | lung-Type_I_Pneumocytes|lung / shred on tissue and cell subclass | 2.14e-04 | 82 | 63 | 3 | 6023212a51f8b3e05e6c3dcf4e8fbf53ba696fb2 | |
| Drug | dioxetane | 1.12e-06 | 29 | 62 | 4 | CID000122029 | |
| Drug | photobiotin | 2.28e-06 | 10 | 62 | 3 | CID003035428 | |
| Drug | 4-aminophenyl phosphate | 7.30e-06 | 2 | 62 | 2 | CID000122270 | |
| Drug | 3-(hydroxymethyl)phenytoin | 7.30e-06 | 2 | 62 | 2 | ctd:C043104 | |
| Drug | 5-bromo-4-chloroindoxyl | 7.30e-06 | 2 | 62 | 2 | CID009964843 | |
| Drug | fast red violet LB salt | 7.30e-06 | 2 | 62 | 2 | CID006370075 | |
| Drug | 5-hydroxycytidine | 2.18e-05 | 3 | 62 | 2 | CID000198207 | |
| Drug | Alphostatin | 2.18e-05 | 3 | 62 | 2 | CID000174788 | |
| Drug | 3-indoxyl phosphate | 4.36e-05 | 4 | 62 | 2 | CID000026292 | |
| Drug | p-bromotetramisole | 4.36e-05 | 4 | 62 | 2 | CID000005121 | |
| Drug | ammediol | 4.36e-05 | 4 | 62 | 2 | CID000001531 | |
| Drug | Fast Blue RR Base | 4.36e-05 | 4 | 62 | 2 | CID000080442 | |
| Drug | Sb15 | 4.36e-05 | 4 | 62 | 2 | CID000044950 | |
| Drug | naphthol AS phosphate | 4.36e-05 | 4 | 62 | 2 | CID000084137 | |
| Drug | ethylethanolamine | 4.36e-05 | 4 | 62 | 2 | CID000008072 | |
| Drug | Fast Blue RR | 7.26e-05 | 5 | 62 | 2 | CID000093116 | |
| Drug | SMR 6 | 7.26e-05 | 5 | 62 | 2 | CID006439864 | |
| Drug | dendrodoine | 7.26e-05 | 5 | 62 | 2 | CID000126514 | |
| Drug | ranelic acid | 7.26e-05 | 5 | 62 | 2 | CID003052774 | |
| Drug | mitomycin phosphate | 7.26e-05 | 5 | 62 | 2 | CID000130219 | |
| Drug | 6-thioxanthosine | 7.26e-05 | 5 | 62 | 2 | CID004023632 | |
| Drug | naphthol AS-TR phosphate | 1.09e-04 | 6 | 62 | 2 | CID000075794 | |
| Drug | O,O,S-trimethylphosphorodithioate | 1.09e-04 | 6 | 62 | 2 | CID000018065 | |
| Drug | 5-fluorosalicylic acid | 1.09e-04 | 6 | 62 | 2 | CID000067658 | |
| Drug | FADP | 1.09e-04 | 6 | 62 | 2 | CID003081481 | |
| Drug | lead;sulfide | 1.09e-04 | 6 | 62 | 2 | CID009794739 | |
| Drug | DSCG | 1.29e-04 | 36 | 62 | 3 | CID003011861 | |
| Drug | Laurdan | 1.52e-04 | 38 | 62 | 3 | CID000104983 | |
| Drug | nitrophenylphosphate | 1.52e-04 | 7 | 62 | 2 | ctd:C008644 | |
| Drug | p-aminodiphenylamine | 1.52e-04 | 7 | 62 | 2 | CID000007564 | |
| Drug | Flutamide [13311-84-7]; Down 200; 14.4uM; MCF7; HT_HG-U133A | 1.86e-04 | 194 | 62 | 5 | 4361_DN | |
| Drug | Mefexamide hydrochloride [3413-64-7]; Up 200; 12.6uM; PC3; HT_HG-U133A | 1.91e-04 | 195 | 62 | 5 | 2121_UP | |
| Drug | Isoconazole [27523-40-6]; Down 200; 9.6uM; PC3; HT_HG-U133A | 1.95e-04 | 196 | 62 | 5 | 2056_DN | |
| Drug | Fluorocurarine chloride [22273-09-2]; Down 200; 11.6uM; HL60; HT_HG-U133A | 1.95e-04 | 196 | 62 | 5 | 2521_DN | |
| Drug | Ticarcillin sodium [4697-14-7]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 2.00e-04 | 197 | 62 | 5 | 7185_DN | |
| Drug | fosfosal | 2.02e-04 | 8 | 62 | 2 | CID000003418 | |
| Drug | iopentol | 2.02e-04 | 8 | 62 | 2 | CID000056016 | |
| Drug | sodium monofluorophosphate | 2.02e-04 | 8 | 62 | 2 | CID000024266 | |
| Drug | (1S,2E,3S)-2-[(2E)-2-[(7aR)-7a-methyl-1-[(E,1R,4R)-1,4,5-trimethylhex-2-enyl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-3-methyl-cyclohexanol | 2.02e-04 | 8 | 62 | 2 | CID011953890 | |
| Drug | orellanine | 2.02e-04 | 8 | 62 | 2 | CID000089579 | |
| Drug | Hydroflumethiazide [135-09-1]; Up 200; 12uM; HL60; HT_HG-U133A | 2.05e-04 | 198 | 62 | 5 | 1851_UP | |
| Drug | Chlorprothixene hydrochloride [6469-93-8]; Up 200; 11.4uM; HL60; HT_HG-U133A | 2.05e-04 | 198 | 62 | 5 | 1272_UP | |
| Drug | CP-320650-01 [172079-28-6]; Up 200; 10uM; PC3; HT_HG-U133A | 2.10e-04 | 199 | 62 | 5 | 3822_UP | |
| Drug | N6,2-O-dibutyryladenosine 3,5-cyclic monophosphate sodium salt; Down 200; 2uM; MCF7; HT_HG-U133A_EA | 2.10e-04 | 199 | 62 | 5 | 959_DN | |
| Drug | lissamine | 2.35e-04 | 44 | 62 | 3 | CID005359521 | |
| Drug | aminohexane | 2.59e-04 | 9 | 62 | 2 | CID000201427 | |
| Drug | phenolphthalein monophosphate | 2.59e-04 | 9 | 62 | 2 | CID000128862 | |
| Drug | R 8231 | 2.59e-04 | 9 | 62 | 2 | CID003084926 | |
| Drug | Ponceau S solution | 2.59e-04 | 9 | 62 | 2 | CID005473620 | |
| Drug | Aphos | 2.59e-04 | 9 | 62 | 2 | CID000053051 | |
| Drug | pingyangmycin | 2.59e-04 | 9 | 62 | 2 | CID000084046 | |
| Drug | fosfluconazole | 2.59e-04 | 9 | 62 | 2 | CID000214356 | |
| Drug | naphthol AS-TR | 2.59e-04 | 9 | 62 | 2 | CID000066718 | |
| Drug | thymol | 2.69e-04 | 46 | 62 | 3 | CID000006989 | |
| Disease | Neurodevelopmental Disorders | 3.94e-05 | 93 | 60 | 4 | C1535926 | |
| Disease | heart rate | 9.57e-05 | 225 | 60 | 5 | EFO_0004326 | |
| Disease | postburn hypertrophic scarring severity measurement | 1.81e-04 | 10 | 60 | 2 | EFO_0007747 | |
| Disease | diffuse scleroderma (is_implicated_in) | 2.21e-04 | 11 | 60 | 2 | DOID:1580 (is_implicated_in) | |
| Disease | triacylglycerol 44:1 measurement | 2.65e-04 | 12 | 60 | 2 | EFO_0010399 | |
| Disease | triacylglycerol 46:2 measurement | 3.64e-04 | 14 | 60 | 2 | EFO_0010402 | |
| Disease | Congenital total cataract | 4.79e-04 | 16 | 60 | 2 | C0266539 | |
| Disease | response to triptolide, cytotoxicity measurement | 4.79e-04 | 16 | 60 | 2 | EFO_0006952, EFO_0007662 | |
| Disease | phosphatidylcholine 40:6 measurement | 5.42e-04 | 17 | 60 | 2 | EFO_0010389 | |
| Disease | triacylglycerol 48:1 measurement | 5.42e-04 | 17 | 60 | 2 | EFO_0010404 | |
| Disease | response to methotrexate, juvenile idiopathic arthritis | 6.80e-04 | 19 | 60 | 2 | EFO_0002609, GO_0031427 | |
| Disease | triacylglycerol 46:1 measurement | 7.55e-04 | 20 | 60 | 2 | EFO_0010401 | |
| Disease | nighttime rest measurement | 1.09e-03 | 24 | 60 | 2 | EFO_0007827 | |
| Disease | triacylglycerol 48:0 measurement | 1.28e-03 | 26 | 60 | 2 | EFO_0010403 | |
| Disease | age at menarche | 1.29e-03 | 594 | 60 | 6 | EFO_0004703 | |
| Disease | cholesteryl ester 14:0 measurement | 1.38e-03 | 27 | 60 | 2 | EFO_0010340 | |
| Disease | neuroimaging measurement | 1.39e-03 | 1069 | 60 | 8 | EFO_0004346 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NPDQDSSSHYHGTSS | 3471 | Q96PZ7 | |
| TFSIPQANHSHSGDY | 171 | P12318 | |
| LQPSSQNHRFYHSTG | 1511 | Q9UKA4 | |
| YSHIPVDSNHNFRSS | 1436 | Q5JWR5 | |
| YNPRRSHSDASVGSH | 1346 | Q6XZF7 | |
| VNRHSYPLSSTSGNA | 446 | Q8WZ64 | |
| HSAGHSQPDGAYSSA | 46 | P56177 | |
| DANTHRPVFQSSHYT | 781 | Q9NYQ6 | |
| GYHHSHTTPQGRSDA | 1516 | P20930 | |
| FRHSQHGSVSYNSNP | 3991 | P20930 | |
| HHLQNATDSGSPSSY | 621 | Q6ZW61 | |
| QNGNPSASEFASHHY | 346 | Q8N7E2 | |
| VSQESGPTYASFSHH | 1461 | Q96BY7 | |
| GNTNSSEPENRTHFH | 61 | Q5JR59 | |
| AENSHSHSDYINASP | 791 | Q92932 | |
| SHVIYNNHQDSSASP | 196 | Q96SQ7 | |
| HESTSSQSLGYDQHG | 456 | Q5D862 | |
| HESRSGQSSYGQHSS | 761 | Q5D862 | |
| SGFGQHESRSHQSSY | 831 | Q5D862 | |
| TRHSYSGHEQTTQTG | 1551 | Q5D862 | |
| YSDSEGHSGFSQRPH | 1806 | Q5D862 | |
| HDSSSRTENPKHSQY | 726 | Q9P2G4 | |
| NTNYNHPHEADSAGT | 1416 | A6NM11 | |
| ATSNPHHDNVRYGIS | 261 | Q9GZY8 | |
| DESNSEPHSQSSYRH | 316 | Q9ULD2 | |
| QGSSRHAAAYTTHPS | 1136 | Q86Z02 | |
| SQPSRASSAYHHASD | 3706 | Q9UPA5 | |
| ASSSREGYVSHHNTP | 426 | Q5T0W9 | |
| EGYVSHHNTPAQSFA | 431 | Q5T0W9 | |
| LHHPRASSTLSYNGT | 316 | P55316 | |
| SSNPYHNSTHSADVL | 551 | O60658 | |
| QSSSYGQHESASRHS | 396 | Q86YZ3 | |
| QHDSSSGQSSSYGQH | 856 | Q86YZ3 | |
| SGQSSSYGQHESASH | 861 | Q86YZ3 | |
| SKSFRHPGYSTQTHV | 96 | P49862 | |
| SSHSLSEYSHGQSPR | 976 | Q7Z3B3 | |
| TQQHSYSSASDPHGR | 66 | Q8NCW0 | |
| SHDSGNFQHRISSSP | 481 | Q6IE36 | |
| SPQENSYVSSTGRAH | 541 | P51617 | |
| QHASPAGTYAHTVNR | 171 | P09923 | |
| TRVQHASPAGTYAHT | 171 | P05187 | |
| NGSSSTSPYNTDHAQ | 126 | Q9H3D4 | |
| HSSHPQGNYSNSKLS | 341 | Q3L8U1 | |
| VSEPRHNHFYSHTTQ | 961 | Q6WRI0 | |
| HHHRGPSDSIANNYS | 101 | Q8TD57 | |
| TSRQQYSSDHSHSSP | 811 | Q53TQ3 | |
| SSPEEVFHSGHSRNS | 216 | Q5T9C2 | |
| VFHSGHSRNSSYASQ | 221 | Q5T9C2 | |
| TDQPSAYSHTHRTFS | 16 | P0C5K7 | |
| PGTTVHRSTYQNHST | 761 | Q14114 | |
| HRSTYQNHSTETPSL | 766 | Q14114 | |
| YGLQNDIRSHSPTHT | 231 | P49802 | |
| TYSNSHGSYDSNQPH | 481 | Q6P3W6 | |
| NNTSISYFSHHSPEQ | 826 | Q5QGS0 | |
| SYFSHHSPEQNEGSL | 831 | Q5QGS0 | |
| PNKQGHSDSHYSSHS | 1271 | O43166 | |
| NRHSKGEPQYSSHSS | 1256 | O60292 | |
| SAVSNSQHYPHRGSG | 1406 | Q9C0A6 | |
| GGTSYSPQENSHNHS | 91 | Q9BTA9 | |
| SSTYSGQHQRVPHAT | 156 | Q6P9B9 | |
| NALSEDTGHSSYPSH | 336 | Q99788 | |
| HGSDHQSPSSSSYNG | 136 | O43298 | |
| NYQHSRSRSPHSSQS | 236 | Q96T58 | |
| YSHENSQGSSHAATK | 651 | P38935 | |
| DLHTNSPRHSKGSYN | 336 | Q9UG56 | |
| PGQSYQSQSRHHDTH | 1006 | Q2KHR2 | |
| SDSSTASPGNHRNHY | 981 | O00507 | |
| HYENQHSPFGTNSET | 161 | Q96JE7 | |
| SYLQSHQSVHSGERP | 706 | Q9UJU3 | |
| YSPSSFQRHERSHTG | 281 | Q8N8L2 | |
| SSSGNYAGSRTHPDH | 141 | Q6UXY8 | |
| TNSQCYSHQRSHSGE | 411 | Q9NZL3 | |
| SSHYSQTDRQGQSSH | 316 | Q6XPR3 | |
| SSHYGQPDTQDQSSH | 376 | Q6XPR3 | |
| SSHYGQPDRQGQNSH | 436 | Q6XPR3 | |
| IYGVTSPQRGHSQHS | 41 | Q7Z2V1 | |
| SDINHSTSGSHYENS | 196 | Q8NDV7 | |
| HYENSQRGPVSSTSD | 206 | Q8NDV7 |